| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13212* | 2021 |
| Tbx2 directly represses the expression of the p21WAF1 cyclin-dependent kinase inhibitor S Prince, S Carreira, KW Vance, A Abrahams, CR Goding Cancer research 64 (5), 1669-1674, 2004 | 206 | 2004 |
| Cervical cancer therapies: Current challenges and future perspectives CA Burmeister, SF Khan, G Schäfer, N Mbatani, T Adams, J Moodley, ... Tumour Virus Research 13, 200238, 2022 | 147 | 2022 |
| The T‐box transcription factor Tbx2: its role in development and possible implication in cancer A Abrahams, MI Parker, S Prince IUBMB life 62 (2), 92-102, 2010 | 130 | 2010 |
| Sequence variants within the 3′-UTR of the COL5A1 gene alters mRNA stability: implications for musculoskeletal soft tissue injuries MJ Laguette, Y Abrahams, S Prince, M Collins Matrix Biology 30 (5-6), 338-345, 2011 | 117 | 2011 |
| Polymorphisms within the COL5A1 3′‐UTR That Alters mRNA Structure and the MIR608 Gene are Associated with Achilles Tendinopathy Y Abrahams, MJ Laguette, S Prince, M Collins Annals of human genetics 77 (3), 204-214, 2013 | 114 | 2013 |
| The highly homologous T-Box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process J Peres, E Davis, S Mowla, DC Bennett, JA Li, S Wansleben, S Prince Genes & cancer 1 (3), 272-282, 2010 | 104 | 2010 |
| The protective role of DOT1L in UV-induced melanomagenesis B Zhu, S Chen, H Wang, C Yin, C Han, C Peng, Z Liu, L Wan, X Zhang, ... Nature communications 9 (1), 259, 2018 | 82 | 2018 |
| T-box transcription factors in cancer biology S Wansleben, J Peres, S Hare, CR Goding, S Prince Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 380-391, 2014 | 75 | 2014 |
| The roles and regulation of TBX3 in development and disease SF Khan, V Damerell, R Omar, M Du Toit, M Khan, HM Maranyane, ... Gene 726, 144223, 2020 | 72 | 2020 |
| The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion J Peres, S Prince Molecular cancer 12, 1-5, 2013 | 72 | 2013 |
| The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway J Li, MS Weinberg, L Zerbini, S Prince Molecular biology of the cell 24 (22), 3569-3576, 2013 | 71 | 2013 |
| Ectopic Tbx2 expression results in polyploidy and cisplatin resistance E Davis, H Teng, B Bilican, MI Parker, B Liu, S Carriera, CR Goding, ... Oncogene 27 (7), 976-984, 2008 | 67 | 2008 |
| A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy S Aliwaini, AJ Swarts, A Blanckenberg, S Mapolie, S Prince Biochemical pharmacology 86 (12), 1650-1663, 2013 | 64 | 2013 |
| Molecular mechanisms underpinning sarcomas and implications for current and future therapy V Damerell, MS Pepper, S Prince Signal transduction and targeted therapy 6 (1), 246, 2021 | 60 | 2021 |
| PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration S Mowla, R Pinnock, VD Leaner, CR Goding, S Prince Biochemical Journal 433 (1), 145-153, 2011 | 60 | 2011 |
| Managing sarcoma: where have we come from and where are we going? JS Bleloch, RD Ballim, S Kimani, J Parkes, E Panieri, T Willmer, S Prince Therapeutic advances in medical oncology 9 (10), 637-659, 2017 | 56 | 2017 |
| UV-mediated regulation of the anti-senescence factor Tbx2 A Abrahams, S Mowla, MI Parker, CR Goding, S Prince Journal of biological chemistry 283 (4), 2223-2230, 2008 | 54 | 2008 |
| The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3 J Li, D Ballim, M Rodriguez, R Cui, CR Goding, H Teng, S Prince Journal of Biological Chemistry 289 (51), 35633-35643, 2014 | 50 | 2014 |
| The T-Box transcription factor 3 in development and cancer T Willmer, A Cooper, J Peres, R Omar, S Prince Bioscience trends 11 (3), 254-266, 2017 | 49 | 2017 |
